Skip to main content
. Author manuscript; available in PMC: 2019 Apr 29.
Published in final edited form as: World J Urol. 2018 Mar 14;36(5):719–726. doi: 10.1007/s00345-018-2263-1

Fig. 5.

Fig. 5

a Coronal images of positive lymph node on 64Cu-TP3805 which was proven malignant by histology. b Comparison of 64Cu-TP3805 DAR analysis of malignant and benign lymph nodes versus histologic H&E analysis. Top—uptake of 64Cu-TP3805 in prostate cancer foci in a malignant lymph node. Bottom—no uptake of 64Cu-TP3805 in benign node (This research was originally published in Tripathi et al. [28])